Hims Hers Health is trading 4.42% up at $32.45, supported by broader market strength as the Nasdaq rises 0.50%.

  • The rebound follows Monday’s Visa-related decline, after reports said the company entered Visa’s monitoring program over elevated weight-loss subscription disputes.
  • The company could face nearly $75,000 in September fees.
  • Hims Hers Health is recovering from the August 24 selloff; no new company-specific positive catalyst was identified.